With Business Insights' portfolio of healthcare reports you benefit from: - insight into macro issues affecting the industry as a whole - timely advice on micro issues involving niche markets - continuous primary research - competitive edge to your decision-making Show All To access FREE information and discover more about a report, click on the title to read a synopsis, browse a table of contents and download supporting marketing materials and press releases. The Impact of US Healthcare Reform on Pharma: Analyzing the effects $3835 After a year of debate and negotiation, in 2010, President Obama signed wide-ranging health reform into law. Published: August 2010 - US Pricing & Reimbursement in Emerging Markets: Analysis of pricing mechanisms and the influence of public and private sector health insurance provision $3835 Over the past few years, pharmaceutical sales in the emerging markets have regularly been growing at double-digit rates, albeit in some of the markets there has been a temporary blip caused by the global credit crunch. Published: August 2010 - Global Immunosuppressants, Organ Transplants, and the Potential of Regenerative Medicine: Market size, competitive landscape, and pipeline analysis $3835 The development of novel immunosuppressants, coupled with advances in immunology, surgical techniques, donor selection and postoperative care have all contributed to improved outcomes for solid organ transplants, which is now established treatment for organ failure of the kidney, pancreas, liver, heart or lung. Published: August 2010 - Global The Cancer Market Outlook to 2015: Competitive landscape, market size, pipeline analysis, and growth opportunities $3835 Global cancer prevalence rates are on the rise owing to an aging population, changing lifestyle and increasing pollution. Published: August 2010 - Global Show All 3 SEPTEMBER 2010